A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)

NCT07121959 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Metformin
DRUG: Belzutifan

Sponsor

Merck Sharp & Dohme LLC